Tumor agnostic efficacy and safety of erdafitinib (erda) in patients (pts) with advanced solid tumors with prespecified FGFR alterations (FGFRalt): RAGNAR primary analysis.
SHENZHEN, China & BEAVERTON, Ore.--(BUSINESS WIRE)--The USB 3.0 Promoter Group today announced the USB Type-C™ Authentication specification, defining cryptographic-based authentication for USB Type-C™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback